William Stohl

University of Southern California
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Objective Systemic lupus erythematosus (SLE) commonly affects women during their childbearing years, making pregnancy experiences especially important to understand. This is particularly true for US Hispanic women, who face a higher SLE burden, more unplanned pregnancies, and frequent language or cultural discordance with clinicians. This study explores their perspectives, focusing on emotional dualities, logistical challenges, and views on unplanned pregnancies. Methods We conducted semistructured interviews with 30 Hispanic women aged 18 to 45 with SLE, recruited from Los Angeles General Medical Center and LupusLA. Eligible participants were heterosexually active or considering pregnancy within three years. Interviews were analyzed using grounded theory to identify themes related to pregnancy experiences, whether actual or hypothetical. Results Three core themes emerged: (1) pregnancy with SLE was marked by a variety of emotions (primarily hope and anxiety); (2) navigating frequent appointments and complex care created logistical strain but also reassurance; and (3) unplanned or poorly timed pregnancies led to a desire for immediate, trusted guidance from their rheumatologist, with most participants preferring continuation if medically feasible. Conclusion Findings highlight the emotional complexity and logistical challenges faced by Hispanic women with SLE. Many of the themes mirror those seen in other chronic disease populations, underscoring that US Hispanic women with SLE, their cultural and linguistic barriers notwithstanding, share many of the same hopes, fears, and needs as other women navigating pregnancy with chronic illness. These results emphasize the need for empathetic, patient‐centered reproductive health care that addresses their emotional, medical, and informational needs.

Year:

2026

Year:

2026

Objective To evaluate the effects of ambient air pollution on rheumatoid arthritis (RA) incidence in a racially/ethnically diverse population. Methods This analysis included 42,152 California Multiethnic Cohort (MEC) participants, ages 65 or older (>70% African American and Latino adults) who were enrolled in the Fee‐for‐Service component of Medicare (2001‐2018). We employed multivariable Cox proportional hazards regression to examine the associations of time‐varying air pollutants based on spatiotemporal models with RA incidence (n=2,027) after adjusting for demographics, neighborhood socioeconomic status (nSES), smoking, work and other exposures. Results RA incidence increased with exposure to fine particulate matter (PM) with diameter ≤2.5 μm (PM 2.5 ) (hazard ratios (HR) [95% CI] per 2 μg/m 3 =1.20 [1.16‐1.23]) and nitrogen dioxide (NO 2 ) HR per 10 μg/m 3 =1.44 [1.35‐1.52]). Air pollutant levels and risk associations were higher in African American and Latino than in Japanese American and White adults (P heterogeneity <0.05). The RA‐PM 2.5 association was higher in men (1.23 [1.15‐1.32]) than in women (1.17 [1.12‐1.21] P heterogeneity =0.06). RA associations with PM 2.5 (and NO 2 ) did not differ by demographics, smoking, or other lifestyle factors but the HR associated with PM 2.5 was higher among those with high‐risk work (longest occupation in labor/craftsman work and exposed to ≥10 years in one or more of 13 industries) (1.29[1.18‐1.41]) than those without high‐risk work exposures (1.16 [1.12‐1.21] P heterogeneity =0.04). Conclusion Exposure to PM and gaseous pollution associates with increased RA incidence after age 65, particularly among African American and Latino adults. Further characterization of air pollution's contribution to racial and ethnic disparities in RA risk is warranted. image

Year:

2026

Objective The objective of this study was to assess clinical laboratory parameters that distinguish between disease flare and infection in febrile patients with systemic lupus erythematosus (SLE) at safety‐net hospitals in Los Angeles. Methods We reviewed electronic medical records of patients admitted from August 1, 2016, through July 31, 2019, categorizing them as disease flare, bacterial infection (culture positive), culture‐negative infection, and both flare and infection. Laboratory parameters collected within 48 hours of admission (complete blood cell count with differential, liver function panel, erythrocyte sedimentation rate [ESR], C‐reactive protein [CRP], C3, C4, lactate, procalcitonin, and ferritin) were analyzed. Results Several laboratory parameters significantly distinguished febrile patients with disease flare from those with infection. An optimized multivariable logistic regression model revealed that an elevated ESR:CRP ratio (>1.17), low white blood cell (WBC) count (<6.25 × 10 9 /L), low absolute neutrophil count (<5.55 × 10 9 /L), and low CRP (<113 mg/L), C3 (<44.5 mg/dL), and C4 (<13.5 mg/dL) levels helped discriminate disease flare from culture‐positive infection. These laboratory parameters yielded areas under the receiving operating characteristic curve of 0.87 (95% confidence interval [CI] 0.76–0.97) for flare versus culture‐positive infection and 0.94 (95% CI 0.88–1.00) for flare versus culture‐negative infection. These optimized models, using multiple laboratory parameters, significantly outperformed the ESR:CRP ratio alone ( P < 0.02) in discriminating flare from infection. Conclusion The ESR:CRP ratio plus C3 and C4 levels, WBC count, neutrophil count, and monocyte count discriminate flare from either culture‐positive or culture‐negative infection in febrile patients with SLE. Our findings warrant prospective validation.

Year:

2025

Objective The aim of this study was to assess sex‐associated disparities in the frequency and magnitude of industry payments to US physician authors in high‐impact rheumatology journals and their correlation with author impact. Methods US authors of publications in four high‐impact rheumatology journals were vetted on Open Payments Database (OPD) for industry payments. The h ‐index (an accepted metric of author impact), physician type, and dollar amounts for each OPD category were recorded. Differences in the percentages of male versus female US authors with or without OPD entries, differences in research‐associated and non–research‐associated payments, and differences in h ‐indexes were determined. Two hematology, two surgery, and two obstetrics/gynecology high‐impact journals were similarly vetted. Results The h ‐indexes of, and industry payments to, US male physician authors were greater than those of and to US female physician authors across all four vetted journal disciplines, with the male‐to‐female ratio of median dollar payments being greatest for rheumatology. Whereas payments to male US physician authors tended to be larger than those to female US physician authors at low h ‐indexes, payments to female US physician authors, especially for rheumatology, tended to match and surpass those to male US physician authors as the h ‐indexes rose. Conclusion Significant differences exist in industry payments and h ‐indexes between male and female US physician authors of publications in high‐impact journals, especially high‐impact rheumatology journals. Sex‐associated differences in industry payments can be attributed, at least in part, to sex‐associated differences in author impact.

Year:

2025

BAFF, a vital B cell survival and differentiation factor, has three receptors: B‐cell maturation antigen (BCMA), transmembrane activator and CAML interactor (TACI) and BR3. Although B cells are greatly reduced in B6. Baff −/− (which harbour no BAFF) and B6. Br3 −/− mice (which harbour supra‐normal levels of BAFF), the distributions of B cell subsets and relationships between Foxp3 + and CD4 + cells in these mice differ. Using a large panel of B6 congenic knockout and/or transgenic mice, we demonstrate that (1) supra‐normal levels of BAFF per se do not explain the phenotypic differences between B6. Baff −/− and B6. Br3 −/− mice; (2) B cells are expanded in B6. Taci −/− mice, with preferential expansion of follicular (FO) B cells at the expense of CD19 + CD21 −/lo CD23 −/lo B cells but without the preferential expansion of Foxp3 + cells observed in B6 mice bearing a Baff transgene; (3) despite no expansion in total B cells, percentages of FO B cells and marginal zone B cells are higher and percentages of CD19 + CD21 −/lo CD23 −/lo B cells are lower in young B6. Bcma −/− mice, consistent with the inability of B6. Br3 −/− .Taci −/− mice to recapitulate the B cell profile of B6. Baff −/− mice; and (4) percentages of Foxp3 + cells in B6. Br3 −/− .Taci −/− mice are intermediate between those in B6. Br3 −/− and B6. Taci −/− mice despite the B cell profile of B6. Br3 −/− .Taci −/− mice strongly resembling that of B6. Br3 −/− mice. Collectively, our findings point to a non‐redundant role for each of the BAFF receptors in determining the ultimate lymphocyte profile of the host. This may have clinically relevant ramifications in that the degree that a candidate therapeutic agent blocks engagement of any given individual BAFF receptor may affect its clinical utility.

Year:

2024

Objective We assessed the contributions of B cell and T cell subsets to the disparate clinical outcomes in NZM. Baff −/− and NZM. Br3 −/− mice. Methods We assessed in NZM wild‐type, NZM. Baff −/− , and NZM. Br3 −/− mice numbers and percentages of B cells and subsets, T cells and subsets, and in vivo proliferation and survival of forkhead box P3 (Foxp3) + cells by fluorescence‐activated cell sorting. Relationships between percentages of Foxp3 + cells and numbers of CD19 + and CD4 + cells were assessed by linear regressions. Results In each age and sex cohort, percentages and numbers of CD19 + cells were similar in NZM. Baff −/− and NZM. Br3 −/− mice. Percentages of CD3 + and CD4 + cells were greater in NZM. Br3 −/− than in NZM. Baff −/− mice, with the CD4 to CD3 cell ratios being greater in NZM. Br3 −/− than in NZM. Baff −/− mice and percentages of Foxp3 + cells in NZM. Br3 −/− mice being lower than in NZM. Baff −/− mice. Percentages of Foxp3 + cells correlated positively with CD19 + cells in NZM. Baff −/− mice but negatively in NZM. Br3 −/− mice. In vivo proliferation and survival of Foxp3 + cells were lower in NZM. Baff −/− mice than in NZM. Br3 −/− mice. Conclusion Differences between NZM. Baff −/− and NZM. Br3 −/− mice in Foxp3 + cells and their relationships with CD19 + cells may have more to do with their divergent clinical outcomes than do differences in numbers of B cells. These unexpected findings suggest that B cell activating factor (BAFF)–B cell maturation antigen (BCMA) or BAFF–Transmembrane activator and calcium‐modulator and cyclophilin ligand interactor (TACI) interactions may help drive development of clinical systemic lupus erythematosus (SLE) even under conditions of considerable B cell depletion. Insufficient blocking of BAFF–BCMA and BAFF–TACI interactions may lie at the heart of incomplete clinical response to BAFF‐targeting agents in human SLE.

Year:

2024

Year:

2023

Year:

2023

Problem Dysregulation of factors vital to the survival B cells and/or plasma cells, such as BAFF and APRIL, could be detrimental to a pregnancy. Method of Study Serially collected first‐, second‐, and third‐trimester serum samples were measured for BAFF and APRIL by ELISA from 150 pregnant women (71 healthy + 79 with a chronic medical disease) at a single medical center. Postpartum serum samples were also collected from the majority of these women. Matched third‐trimester and cord blood samples were collected from 168 women (86 healthy + 82 with a chronic medical disease). Data were analyzed by chi‐square statistic, unpaired t ‐test, paired t ‐test, Mann‐Whitney rank sum test, Wilcoxon signed rank test, Spearman rank order correlation, and receiver operator characteristic (ROC) curve analyses as appropriate. Results Maternal serum BAFF levels declined as the pregnancies progressed and rebounded postpartum, whereas serum APRIL levels remained relatively flat throughout pregnancy and postpartum. Cord BAFF and APRIL levels correlated positively with gestation age and were considerably greater than the corresponding maternal third‐trimester serum BAFF and APRIL levels, respectively. In women who developed preeclampsia, third‐trimester BAFF levels were greater, rather than lower, than their corresponding second‐trimester BAFF levels. ROC curve analysis suggested a potential role for third‐trimester serum BAFF level as a biomarker of preeclampsia. Conclusions BAFF and APRIL are differentially regulated in the mother during and following pregnancy, whereas each is upregulated in the developing fetus. An increase in third‐trimester serum BAFF level may portend development of preeclampsia.

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (3)

Leanna Wise

-

UNITED STATES
View details

Melissa Wilson

Associate Professor

University of Southern California

UNITED STATES
View details

Anna H. Wu

Professor

University of Southern California

UNITED STATES
View details